Kalaris Therapeutics, Inc.
KLRS
$5.54
$0.071.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 77.00M | 88.43M | 100.97M | 1.91M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 1.18M | 3.23M | 1.22M | 234.00K | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 78.18M | 91.65M | 102.18M | 2.15M | |
|
|
|||||
| Total Current Assets | 78.18M | 91.65M | 102.18M | 2.15M | |
| Net Property, Plant & Equipment | 1.52M | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 1.48M | 1.19M | 910.00K | 314.00K | |
| Total Assets | 81.18M | 92.84M | 103.09M | 2.46M | |
|
|
|||||
| Total Accounts Payable | 494.00K | 3.68M | 2.37M | 2.23M | |
| Total Accrued Expenses | 5.20M | 3.83M | 4.54M | 619.00K | |
| Short-term Debt | -- | -- | -- | 9.25M | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 376.00K | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | 142.00K | 230.00K | 1.67M | |
| Total Other Current Liabilities | -- | 142.00K | 230.00K | 1.67M | |
| Total Current Liabilities | 6.07M | 7.65M | 7.14M | 13.77M | |
|
|
|||||
| Total Current Liabilities | 6.07M | 7.65M | 7.14M | 13.77M | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | 9.25M | |
| Capital Leases | 1.17M | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 32.08M | 32.08M | 32.08M | 32.08M | |
| Total Liabilities | 39.31M | 39.73M | 39.22M | 45.84M | |
|
|
|||||
| Common Stock & APIC | 191.86M | 191.22M | 190.63M | 5.16M | |
| Retained Earnings | -150.00M | -138.11M | -126.76M | -94.54M | |
| Treasury Stock & Other | 6.00K | -- | -- | -- | |
| Total Common Equity | 41.87M | 53.12M | 63.87M | -89.38M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | 46.00M | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 46.00M | |
|
|
|||||
| Total Common Equity | 41.87M | 53.12M | 63.87M | -89.38M | |
| Total Preferred Equity | -- | -- | -- | 46.00M | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 41.87M | 53.12M | 63.87M | -43.38M | |
|
|
|||||